Fennec Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Fennec Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Fennec Pharmaceuticals Inc
Rating: 2.23933325
Author: Trendlyne DVM scores

about

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The comp...

8.78 -0.26 (-2.88%)

New 52W High today

109.4K

XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

18.8 / 100

Technically Bullish

70.7 / 100

1Yr Price target upside is 57%

5 analysts

Fennec Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Fennec Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The comp...

New 52W High today

SWOT Analysis

Fennec Pharmaceuticals Inc Live Price Chart